NBPF7 Antibody

Basic Research Questions

• What is NBPF7 and what cellular functions has it been linked to in research?

  NBPF7 (Neuroblastoma breakpoint family member 7) is a protein belonging to the neuroblastoma breakpoint family with a molecular weight of approximately 48 kDa . Research has demonstrated that NBPF7 plays a significant role in cellular proliferation, particularly in keratinocytes. Studies have shown that NBPF7 is upregulated in α-catenin-knockdown HaCaT cells and functions through a linkage with the NF-κB pathway to promote cell proliferation . This connection to the NF-κB signaling pathway suggests NBPF7 may be involved in important cellular growth regulatory mechanisms. When NBPF7 is inhibited through targeted knockdown, reduced cell proliferation is observed, indicating its potential importance in cell growth control systems .

• What are the recommended applications for NBPF7 antibodies in experimental protocols?

  NBPF7 antibodies have been validated for multiple experimental applications with specific dilution recommendations:

  Application	Recommended Dilution	Notes
  Western Blot (WB)	1:500-1:3000	Detects denatured NBPF7 protein
  Immunohistochemistry (IHC)	1:50-1:200	For paraffin or frozen tissue sections
  Immunofluorescence (IF/ICC)	1:100-1:500	For cellular localization studies
  ELISA	1:35000-1:40000	For quantitative analysis

  When designing experiments, optimal dilutions should be determined empirically for each specific application and sample type. For meaningful results, appropriate positive and negative controls should be included in each experiment to validate antibody specificity .

• What is the typical reactivity profile of commercially available NBPF7 antibodies?

  Most commercially available NBPF7 antibodies demonstrate specific reactivity to human NBPF7, with some antibodies also cross-reacting with mouse NBPF7 . The specificity profile indicates that these antibodies detect endogenous levels of total NBPF7 protein . When selecting an antibody for your research, it's important to verify the reactivity claims through the manufacturer's validation data and consider performing your own validation if working with species not explicitly tested. For cross-species studies, choose antibodies specifically validated for multiple species reactivity to ensure reliable results .

• What are the optimal storage conditions for maintaining NBPF7 antibody activity?

  To maintain optimal activity of NBPF7 antibodies, follow these storage recommendations:

  • Store at -20°C in aliquots to minimize freeze/thaw cycles

  • Most NBPF7 antibodies are supplied in PBS (pH 7.4) containing 150mM NaCl, 0.02% sodium azide, and 50% glycerol

  • Antibodies stored according to manufacturer recommendations are typically stable for 12 months from date of receipt

  • When handling antibodies, always use clean pipette tips and sterile technique to prevent contamination

  • For daily use, small working aliquots can be kept at 4°C for up to one week, but extended storage at this temperature is not recommended

  Multiple freeze/thaw cycles can lead to reduced antibody activity and increased background in experimental applications, so proper aliquoting upon receipt is essential for maintaining antibody performance over time .

Advanced Research Questions

• How can researchers validate NBPF7 antibody specificity in experimental systems?

  Validating NBPF7 antibody specificity is critical for ensuring experimental reliability. A comprehensive validation approach should include:

  1. Knockdown/Knockout Controls: Use NBPF7-specific shRNAs to create knockdown cell lines as negative controls. In published research, shRNA targeting NBPF7 significantly decreased both mRNA and protein levels in HaCaT cells, providing a valuable negative control system .

  2. Peptide Competition Assays: Pre-incubate the antibody with the immunizing peptide before application to samples. Signal elimination confirms binding specificity to the target epitope.

  3. Multiple Antibody Comparison: Use different antibodies targeting distinct NBPF7 epitopes. Concordant results strengthen specificity confidence.

  4. Western Blot Molecular Weight Verification: Confirm detection at the expected 48 kDa band position, as documented for NBPF7 .

  5. Cross-reactivity Assessment: When using antibodies in multiple species, validate with species-specific positive controls to ensure equivalent reactivity .

  6. Positive Controls: Use cell lines known to express NBPF7 (such as HaCaT cells with α-catenin knockdown, which show elevated NBPF7 expression) .

  These validation steps should be documented and included in publications to ensure experimental reproducibility.

• What methodological considerations are important when studying NBPF7 interactions with the NF-κB pathway?

  When investigating NBPF7 interactions with the NF-κB pathway, several methodological considerations are crucial:

  1. Co-immunoprecipitation Approaches: Research has demonstrated that NBPF7 can be detected in endogenous p65 (a key NF-κB component) immunoprecipitates from α-catenin-knockdown HaCaT cells . When designing co-IP experiments:

     • Use antibodies that can specifically recognize NBPF7 and NF-κB components

     • Include appropriate negative controls (IgG or unrelated antibody)

     • Consider both forward and reverse co-IP approaches to strengthen interaction evidence

  2. Co-localization Studies: Immunofluorescence analyses have shown co-localization of p65 and NBPF7 in the nucleus of α-catenin-knockdown HaCaT cells . For robust co-localization data:

     • Use high-resolution imaging techniques

     • Apply quantitative co-localization analysis methods

     • Include appropriate negative controls

  3. Functional Validation: Research shows that while NBPF7 knockdown decreases cell proliferation, it does not alter mRNA and protein levels of IκBα and p65 . This suggests NBPF7 functions in parallel to or downstream of the NF-κB pathway rather than directly regulating NF-κB component expression.

  4. Signal Pathway Analysis: When studying this interaction, consider examining:

     • Nuclear translocation of NF-κB components

     • Expression of NF-κB target genes

     • Phosphorylation states of pathway components

  Understanding these methodological nuances is essential for accurately characterizing the functional relationship between NBPF7 and the NF-κB pathway in cell proliferation regulation.

• How can researchers optimize Western blot protocols specifically for NBPF7 detection?

  Optimizing Western blot protocols for NBPF7 detection requires attention to several key parameters:

  1. Sample Preparation:

     • Use appropriate lysis buffers containing protease inhibitors to prevent protein degradation

     • Heat samples at 95°C for 5 minutes in SDS loading buffer to ensure complete denaturation

     • Load 20-50 μg of total protein per lane for optimal detection of endogenous NBPF7

  2. Gel Electrophoresis and Transfer:

     • Use 10-12% SDS-PAGE gels for optimal resolution of the 48 kDa NBPF7 protein

     • Transfer to PVDF membranes at 100V for 60-90 minutes in cold transfer buffer containing 20% methanol

     • Verify transfer efficiency with reversible protein staining before blocking

  3. Antibody Incubation:

     • Block membranes with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

     • Incubate with primary NBPF7 antibody at dilutions of 1:500-1:1000 in blocking buffer overnight at 4°C

     • Wash extensively with TBST (4-5 times, 5 minutes each)

     • Incubate with appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG at 1:5000-1:10000) for 1 hour at room temperature

  4. Detection and Analysis:

     • Use enhanced chemiluminescence (ECL) detection systems

     • For weak signals, consider using more sensitive ECL substrates or longer exposure times

     • Include molecular weight markers to confirm the expected 48 kDa band position

     • Use β-actin or GAPDH as loading controls for normalization

  5. Troubleshooting Common Issues:

     • If multiple bands appear, increase blocking time or antibody dilution

     • If no signal is detected, reduce antibody dilution or increase protein loading

     • For high background, increase washing steps or reduce antibody concentration

  Following these optimized protocols will help ensure specific and sensitive detection of NBPF7 in Western blot applications.

• What considerations are important when designing NBPF7 knockdown experiments?

  When designing NBPF7 knockdown experiments, researchers should consider:

  1. Knockdown Strategy Selection:

     • Published research has successfully used lentivirus-mediated shRNA delivery systems to knockdown NBPF7 in HaCaT cells

     • Consider both transient (siRNA) and stable (shRNA) knockdown approaches based on experimental timeline

     • For comprehensive analysis, use multiple shRNA/siRNA sequences targeting different regions of NBPF7 mRNA

  2. Knockdown Validation:

     • Confirm knockdown efficiency at both mRNA level (using qRT-PCR) and protein level (using Western blot)

     • Acceptable knockdown efficiency should typically exceed 70% reduction compared to control cells

  3. Control Selection:

     • Include non-targeting shRNA/siRNA controls with similar GC content to the NBPF7-targeting sequences

     • In experiments involving α-catenin knockdown HaCaT cells, appropriate controls should include wild-type HaCaT cells, α-catenin knockdown cells, and α-catenin/NBPF7 double knockdown cells

  4. Functional Readouts:

     • Cell proliferation assays have been successfully used to assess NBPF7 knockdown effects

     • Consider additional functional assays based on research questions (migration, invasion, apoptosis)

     • Examine NF-κB pathway components and target genes to assess pathway involvement

  5. Rescue Experiments:

     • Perform rescue experiments by re-expressing shRNA-resistant NBPF7 to confirm phenotype specificity

     • Use proper controls for rescue experiments, including empty vector controls

  Adhering to these considerations will help ensure robust and reproducible NBPF7 knockdown experimental designs.

• How can researchers differentiate between NBPF family members when using antibodies?

  Differentiating between NBPF family members is challenging due to sequence homology. Researchers should employ these strategies:

  1. Antibody Selection:

     • Choose antibodies raised against unique regions of NBPF7 that have minimal sequence homology with other family members

     • Review the immunogen information provided by manufacturers - antibodies raised against C-terminal regions of NBPF7 may offer better specificity

     • Some antibodies can recognize multiple NBPF family members, so carefully review specificity data

  2. Validation Approaches:

     • Perform peptide competition assays with peptides specific to NBPF7 and related family members

     • Use genetic models: compare antibody reactivity in wild-type cells versus NBPF7-specific knockdown cells

     • When possible, use recombinant NBPF proteins as positive controls for specificity testing

  3. Complementary Techniques:

     • Combine antibody-based detection with mRNA analysis using NBPF7-specific primers

     • For complex samples, consider using immunoprecipitation followed by mass spectrometry to confirm protein identity

     • Use multiple antibodies targeting different epitopes of NBPF7 to increase confidence in specificity

  4. Data Interpretation:

     • When analyzing results, consider potential cross-reactivity with other NBPF family members

     • Be cautious when interpreting results from tissues/cells known to express multiple NBPF proteins

     • Clearly document antibody specifications and validation methods in research publications

  These approaches will help researchers differentiate NBPF7 from other family members and increase confidence in experimental results.

• What are the key considerations for using NBPF7 antibodies in co-immunoprecipitation studies?

  When performing co-immunoprecipitation (Co-IP) studies with NBPF7 antibodies, researchers should consider:

  1. Antibody Selection:

     • Choose antibodies validated for immunoprecipitation applications

     • Consider using NBPF antibodies that can recognize most NBPF members for initial screening, followed by NBPF7-specific antibodies for confirmation

     • Antibody orientation is critical - decide whether to use the NBPF7 antibody for pull-down or for detection in the subsequent Western blot

  2. Experimental Controls:

     • Include negative controls: IgG from the same species as the antibody or an antibody against an unrelated protein

     • Use positive controls: cells with known NBPF7 interactions, such as α-catenin-knockdown HaCaT cells for p65/NBPF7 interactions

     • Perform reverse Co-IP (using antibodies against the interacting protein for pull-down) to confirm interactions

  3. Lysis and IP Conditions:

     • Use mild lysis buffers (containing 0.5-1% NP-40 or Triton X-100) to preserve protein-protein interactions

     • Include protease and phosphatase inhibitors to prevent degradation and modification

     • Optimize antibody amount: typically 2-5 μg per 500 μg of total protein

     • Consider cross-linking antibodies to beads to avoid IgG contamination in eluates

  4. Detection Methods:

     • When confirming NBPF7 interaction with NF-κB components, use antibodies that specifically recognize p65 and NBPF7

     • For Western blot detection after Co-IP, use higher antibody concentrations than standard Western blot protocols

     • Consider using protein A/G magnetic beads for improved pull-down efficiency with less background

  5. Data Interpretation:

     • Quantify the relative amounts of co-immunoprecipitated proteins compared to input samples

     • Be cautious of non-specific binding, particularly when working with proteins that have potential sticky domains

  These considerations will help ensure robust and reliable results when studying NBPF7 protein-protein interactions through co-immunoprecipitation.

• How can researchers interpret contradictory results when studying NBPF7 function?

  When faced with contradictory results in NBPF7 research, consider these methodological approaches:

  1. Technical Variation Assessment:

     • Analyze differences in antibody clones, host species, or immunogen epitopes across studies

     • Compare detection methods: direct labeling versus secondary antibody detection systems

     • Evaluate differences in experimental protocols, particularly fixation methods for IF/ICC studies

  2. Biological Context Considerations:

     • Cell type-specific effects: NBPF7 function may differ between cell types (e.g., HaCaT keratinocytes versus other cell lines)

     • Examine context-dependent interactions: NBPF7-NF-κB pathway interactions may be influenced by cellular conditions like α-catenin expression levels

     • Consider post-translational modifications that may affect antibody recognition or protein function

  3. Experimental Design Reconciliation:

     • When conflicting results occur between knockdown phenotypes and overexpression studies, consider dose-dependent effects

     • For contradictions between mRNA and protein levels, investigate potential post-transcriptional regulation mechanisms

     • When functional studies disagree, examine differences in functional readouts and time points

  4. Validation Approaches:

     • Use orthogonal methods to validate key findings (e.g., combine antibody-based detection with genetic approaches)

     • Perform rescue experiments to confirm specificity of observed phenotypes

     • Include additional controls to rule out off-target effects

  5. Data Integration Strategies:

     • Develop models that can accommodate seemingly contradictory results (e.g., cell-type specific or context-dependent models)

     • Perform careful kinetic studies to determine if contradictions reflect different time points in a dynamic process

     • Consider potential compensatory mechanisms that may mask NBPF7 function in certain experimental systems

  By systematically addressing these considerations, researchers can resolve apparent contradictions and develop more nuanced models of NBPF7 function.

• What are the best practices for using NBPF7 antibodies in multiplexed immunofluorescence applications?

  For optimal results in multiplexed immunofluorescence studies involving NBPF7 antibodies:

  1. Antibody Compatibility Planning:

     • Select NBPF7 antibodies from different host species than other target antibodies to avoid cross-reactivity

     • If using multiple rabbit antibodies, consider sequential immunostaining with direct labeling or using Fab fragment blocking between rounds

     • Verify that secondary antibodies do not cross-react with primaries from different species

  2. Protocol Optimization:

     • Perform titration experiments for each antibody in the multiplex panel to determine optimal concentrations

     • Use appropriate fixation methods: paraformaldehyde fixation (4%) has been successfully used for NBPF7 immunofluorescence

     • Include single-color controls to assess bleed-through and spectral overlap

  3. Co-localization Analysis:

     • For NBPF7 and NF-κB co-localization studies, use high-resolution confocal microscopy

     • Apply quantitative co-localization algorithms (Pearson's correlation, Manders' overlap coefficient)

     • Include appropriate negative controls (proteins known not to co-localize with NBPF7)

  4. Signal Amplification Considerations:

     • For low-abundance targets, consider tyramide signal amplification or other amplification methods

     • If using amplification, carefully titrate reagents to avoid signal saturation and non-specific staining

     • Include appropriate controls for each amplification step

  5. Image Acquisition and Analysis Best Practices:

     • Use sequential scanning to minimize spectral overlap when imaging NBPF7 alongside other targets

     • Apply consistent imaging parameters across experimental and control samples

     • Use appropriate software tools for quantitative analysis of co-localization (ImageJ, CellProfiler)

     • Perform ratiometric analysis to assess relative levels of NBPF7 and interacting proteins

  These best practices will enable researchers to generate reliable multiplexed immunofluorescence data when studying NBPF7 localization and interactions with other proteins.